SHSCX
BlackRock Health Sciences Opportunities Portfolio
1W: -2.6%
1M: -3.7%
3M: -11.2%
YTD: -6.0%
1Y: +2.8%
3Y: +4.0%
5Y: -18.1%
$47.05
-0.05 (-0.11%)
Weekly Expected Move ±2.0%
$45
$46
$47
$48
$49
ETF-Level Metrics
AUM$6.4B
Holdings107
Top 10 Wt43.8%
Beta0.51
% Profitable26%
Coverage68%
Portfolio Valuation
P/E13337.7
P/B2621.4
P/S1398.4
EV/EBITDA18.2
P/FCF8101.1
PEG—
Profitability & Returns
Gross Margin62.2%
Net Margin9.8%
ROE18.6%
ROA6.1%
ROIC22.1%
Div Yield1.35%
Leverage & Liquidity
Debt/Equity1.07
Debt/Assets0.34
Net Debt/EBITDA1.7x
Interest Cov10.5x
Current Ratio1.18
Quick Ratio0.95
Growth (YoY)
Revenue+15.6%
Net Income-8.3%
EPS-16.6%
FCF+27.4%
EBITDA-0.7%
Rev CAGR 3Y+15.8%
Quality Scores
Piotroski F5.6
Altman Z10.21
IS Quality66.9
IS Overall57.0
IS Value39.3
Median P/E-4.0
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 108 | 77.3% | -7.9 |
| Other | 31 | 22.7% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 139 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY Private | — | 11.91% | $759.6M | 656,650 | — | — | — |
| 2 | JOHNSON & JOHNSON | JNJ | 8.02% | $511.7M | 1,924,600 | 29.6 | $617.0B | Healthcare |
| 3 | MERCK & CO INC | MRK | 5.56% | $354.7M | 2,400,258 | 114.5 | $356.4B | Healthcare |
| 4 | ABBVIE | ABBV.BA | 5.07% | $323.4M | 1,261,298 | 74.0 | $754.9T | Healthcare |
| 5 | THERMO FISHER SCIENTIFIC INC | TMO.TO | 4.41% | $281.1M | 455,530 | — | $338.8B | Healthcare |
| 6 | UNITEDHEALTH GROUP INC | UNH.TO | 4.33% | $276.1M | 708,976 | — | $15.2B | Healthcare |
| 7 | GILEAD SCIENCES | GILD | 4.09% | $261.0M | 1,783,230 | -55.7 | $179.5B | Healthcare |
| 8 | AMGEN INC | AMGN | 3.98% | $253.7M | 590,203 | 24.8 | $217.5B | Healthcare |
| 9 | VERTEX PHARMACEUTICALS | VRTX | 3.33% | $212.5M | 390,198 | 29.1 | $128.1B | Healthcare |
| 10 | ABBOTT LABORATORIES | ABT | 2.61% | $166.6M | 1,509,463 | 31.4 | $168.7B | Healthcare |
| 11 | PFIZER | PFE.BA | 2.39% | $152.7M | 5,365,585 | 36.7 | $256.4T | Healthcare |
| 12 | DANAHER Private | — | 2.28% | $145.7M | 682,443 | — | — | — |
| 13 | EDWARDS LIFESCIENCES | EW | 2.27% | $144.7M | 1,594,693 | 48.9 | $49.0B | Healthcare |
| 14 | ELEVANCE HEALTH INC | ANTM | 1.86% | $118.7M | 302,439 | 2.1 | $114.6B | Healthcare |
| 15 | STRYKER Private | — | 1.80% | $114.9M | 354,942 | — | — | — |
| 16 | BRISTOL MYERS SQUIBB Private | — | 1.77% | $112.9M | 1,690,485 | — | — | — |
| 17 | ARGENX SE ADR | ARGX.BR | 1.54% | $98.1M | 95,059 | 33.3 | $50.7B | Healthcare |
| 18 | BIOGEN | BIIB | 1.24% | $78.9M | 364,188 | 38.7 | $32.5B | Healthcare |
| 19 | TEVA PHARMACEUTICAL INDUSTRIES ADR | TEVA.TA | 1.21% | $77.2M | 2,140,996 | 63.2 | $141.6B | Healthcare |
| 20 | REVOLUTION MEDICINES | RVMD | 1.16% | $74.3M | 361,340 | -23.3 | $43.9B | Healthcare |
| 21 | WATERS CORP | WAT | 1.13% | $72.3M | 174,359 | 105.8 | $41.7B | Healthcare |
| 22 | IQVIA HOLDINGS | IQV | 1.08% | $68.6M | 262,637 | 31.8 | $42.5B | Healthcare |
| 23 | MODERNA | MRNA | 0.98% | $62.4M | 444,967 | -23.8 | $75.4B | Healthcare |
| 24 | ILLUMINA INC | ILMN | 0.95% | $60.8M | 284,747 | 50.5 | $41.3B | Healthcare |
| 25 | DEXCOM INC | DXCM | 0.95% | $60.4M | 663,769 | 33.0 | $32.2B | Healthcare |
| 26 | BOSTON SCIENTIFIC CORP Private | — | 0.94% | $59.9M | 1,240,969 | — | — | — |
| 27 | BLACKROCK LIQ FUND T-FD-IN Private | — | 0.92% | $59.0M | 58,952,234 | — | — | — |
| 28 | HCA HEALTHCARE | HCA | 0.89% | $57.1M | 137,660 | 14.2 | $92.4B | Healthcare |
| 29 | INCYTE CORP | INCY | 0.85% | $54.2M | 439,661 | 14.2 | $23.4B | Healthcare |
| 30 | PROTAGONIST THERAPEUTICS | PTGX | 0.76% | $48.2M | 326,162 | 115.0 | $9.0B | Healthcare |
| 31 | CYTOKINETICS | CYTK | 0.72% | $46.1M | 649,484 | -9.1 | $8.2B | Healthcare |
| 32 | PENUMBRA | PEN | 0.67% | $43.0M | 133,216 | 77.6 | $12.5B | Healthcare |
| 33 | AGILENT TECHNOLOGIES INC | A | 0.65% | $41.7M | 271,239 | 33.0 | $47.4B | Healthcare |
| 34 | TENET HEALTHCARE CORP | THC | 0.64% | $41.0M | 154,007 | 9.9 | $20.8B | Healthcare |
| 35 | GALDERMA GROUP N AG | GALD.SW | 0.61% | $39.1M | 188,090 | 47.4 | $37.4B | Healthcare |
| 36 | CENCORA | COR | 0.61% | $39.0M | 120,395 | 22.9 | $60.1B | Healthcare |
| 37 | INSMED Private | — | 0.57% | $36.5M | 299,235 | — | — | — |
| 38 | COGENT BIOSCIENCES | COGT | 0.57% | $36.1M | 1,030,762 | -13.4 | $5.3B | Healthcare |
| 39 | APOGEE THERAPEUTICS | APGE | 0.56% | $35.6M | 263,702 | -31.1 | $8.4B | Healthcare |
| 40 | NOVARTIS ADR REPRESENTING AG | NVS | 0.49% | $31.6M | 207,638 | 21.3 | $268.0B | Healthcare |
| 41 | HUMANA | HUM.ST | 0.45% | $28.9M | 75,328 | 20.3 | $3.4B | Healthcare |
| 42 | UNITED THERAPEUTICS | UTHR | 0.45% | $28.4M | 55,689 | 17.9 | $23.0B | Healthcare |
| 43 | LB PHARMACEUTICALS INC | LBRX | 0.42% | $26.8M | 567,627 | -12.5 | $1.1B | Healthcare |
| 44 | HALOZYME THERAPEUTICS | HALO | 0.41% | $26.2M | 246,253 | 31.2 | $13.0B | Healthcare |
| 45 | TEMPUS AI CLASS A | TEM | 0.41% | $26.1M | 414,285 | -53.6 | $13.4B | Healthcare |
| 46 | CVS HEALTH | CVS | 0.39% | $24.6M | 262,347 | 22.6 | $110.3B | Healthcare |
| 47 | ORUKA THERAPEUTICS INC | ORKA | 0.38% | $24.5M | 264,813 | -34.2 | $5.1B | Healthcare |
| 48 | MCKESSON CORP | MCK | 0.38% | $24.4M | 27,586 | 24.0 | $105.6B | Healthcare |
| 49 | BRUKER Private | — | 0.36% | $22.9M | 394,770 | — | — | — |
| 50 | ERASCA | ERAS | 0.35% | $22.6M | 1,261,812 | -15.5 | $5.1B | Healthcare |